Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis
Recruiting · NCT06801821 · Observational (researchers observe without assigning treatment) · Lead sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
View the official record on ClinicalTrials.gov →What this trial is about
Primary objective: The primary objective is to evaluate in the general population the difference between emotional reactions associated with facial involvement by four major dermatologic diseases: psoriasis, atopic dermatitis, vitiligo, and alopecia areata. * Compare the social distance and stereotyping by the general population toward individuals with facial involvement by: psoriasis, atopic dermatitis, vitiligo, and alopecia areata. * Evaluate demographic factors that describe a greater tendency toward stigmatization.
Who can take part
Inclusion criteria
- -Patients aged\>18 years, both sexes;
- Signature of written informed consent;
Exclusion criteria
- Patients diagnosed with psoriasis, atopic dermatitis, vitiligo or alopecia areata.
- Patients with first-degree relatives with psoriasis, atopic dermatitis, vitiligo or alopecia areata
- Those who for professional or personal reasons have direct knowledge of the diseases in question.
Where it is running
2 locations listed.
- Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Dermatologia - Roma, Italia, Italy
- Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Dermatologia - Roma, Italia, Italy